New perspectives on an ancient pathogen: thoughts for World Tuberculosis Day 2022.
New perspectives on an ancient pathogen: thoughts for World Tuberculosis Day 2022.
复制标题
一种古老病原体的新视角:2022年世界结核病日的思考。
DOI:
10.1099/mic.0.001178
复制
发表时间:
2022-03
期刊:
影响因子:
2.8
通讯作者:
Beste, Dany J. V.
中科院分区:
文献类型:
--
作者:
Beste, Dany J. V.
The last special edition dedicated to mycobacteria was in 2003 and focused on the promise of the post-genomic era to deliver significant advances in mycobacterial research [1]. In the intervening decades we have advanced our understanding about the basic biology of this important group of bacteria. Next-generation sequencing has revolutionized our knowledge of the evolutionary dynamics of mycobacteria, including the development of drug resistance [2]. There have also been innovations in terms of tuberculosis (TB) diagnostics and control measures, including new antibiotics, which have translated into a reduction in cases and death rates from this disease. However, disruption of TB control measures has sadly been amongst the collateral damage of the coronavirus disease 2019 (COVID-19) pandemic, and in 2020 we saw the first increase in TB deaths recorded for over a decade [3]. This is predicted to setback the World Health Organization’s (WHO’s) strategy for reducing the global burden of TB by~ 12 years [4]. Mycobacterial research remains massively underfunded, non-TB mycobacterial infections are on the rise and Mycobacterium bovis remains a dominant cause of bovine and zoonotic TB worldwide. Despite these impediments, mycobacterial researchers continue to deliver exciting and cutting-edge research, as exemplified in this special issue of Microbiology.Mycobacterial researchers have led the way in the emerging frontiers of pathometabolism and immunometabolism. We now have a much better understanding of the dietary requirements of this pathogen when it is growing within its human host [2] and how M. tuberculosis affects its host’s metabolism and immunity. Attention is now being redirected to understanding the battle for metal ions during host pathogen interactions. Understanding metal acquisition by mycobacteria and how metals are used by the host as bacteriostatic/bactericidal weapons is the focus of a review by Serafini and a study by Tamuhla et al.[5, 6]. Serafini reviews our limited knowledge of the interplay between central carbon metabolism and metal homeostasis and how this could lead to the development of anti-TB drugs [5]. Tamuhla and colleagues defined new genetic mechanisms by which M. smegmatis adapts to low iron stress [6].
登录
查看更多内容
DOI:
10.1099/mic.0.000952
发表时间:
2020-09
期刊:
Microbiology (Reading, England)
影响因子:
--
作者:
Pickford H;Alcock E;Singh A;Kelemen G;Bhatt A
通讯作者:
Bhatt A
影响因子:
2.8
作者:
Singh, Shweta;Godavarthi, Sapna;Sen, Ranjan
通讯作者:
Sen, Ranjan
影响因子:
2.8
作者:
Di Capua, Cecilia B.;Belardinelli, Juan M.;Morbidoni, Hector R.
通讯作者:
Morbidoni, Hector R.
影响因子:
2.8
作者:
Fowler, Philip W.;Cruz, Ana Luiza Gibertoni;Crook, Derrick W.
通讯作者:
Crook, Derrick W.
影响因子:
2.8
作者:
Chatterjee, Ayan;Sharma, Arun Kumar;Kundu, Manikuntala
通讯作者:
Kundu, Manikuntala